We were encouraged to see some very promising results from a Phase II clinical trial for high grade Neuroendocrine Carcinoma (NEC) patients, using a combination of Immunotherapy drugs. The results of this trial were recently presented at the American Association for Cancer Research Annual Meeting.
Click here for link to full press release
We welcome more research for these NEC patients and all NET Cancer patients and look forward to seeing more results based on real world experience.
Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.
Shaping the future of cancer control together We are pleased to send you this update on the Australian Cancer Plan, the first national 10-year
Recruiting NET health professionals for International Delphi survey Development of a neuroendocrine tumour (NET) nutrition-risk screening tool to identify patients requiring nutrition intervention and education
All donations are tax deductible.
Registered Charity CFN 202607
© 2020 NeuroEndocrine Cancer Australia
